P. 1
Sjögren’s Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Sjögren’s Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019

|Views: 7|Likes:
Published by aarkstor

More info:

Published by: aarkstor on Jun 28, 2012
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as DOCX, PDF, TXT or read online from Scribd
See more
See less

12/23/2014

pdf

text

original

Sjögren’s Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Summary company, the industry analysis specialist, has released its new report, “Sjögren’s Syndrome Therapeutics Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Sjogrens Syndrome Therapeutics market. The report identifies the key trends shaping and driving the global Sjogrens Syndrome Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Sjogrens Syndrome Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by company’s team of industry experts. Scope The report provides information on the key drivers and challenges of the Sjogrens Syndrome Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Sjogrens Syndrome Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Sjogrens Syndrome Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Sjogrens Syndrome Therapeutics market. - Analysis of key recent licensing and partnership agreements in Sjogrens Syndrome Therapeutics market Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Sjogrens Syndrome Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Sjogrens Syndrome Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Sjogrens Syndrome Therapeutics market landscape? – Identify, understand and capitalize. 1.1 List of Tables 5 1.2 List of Figures 6 2 Sjögren’s Syndrome Therapeutics - Introduction 7 2.1 Overview 7 2.2 Epidemiology 7 2.3 Signs and Symptoms 7 2.3.1 Ocular Manifestation: 7 2.3.2 Oral Manifestation: 7

2.3.3 Systemic Manifestation: 7 2.4 Etiology 8 2.5 Pathophysiology 8 2.5.1 Cell Mediated 9 2.5.2 Inflammatory response 9 2.6 Diagnosis of Sjögren’s Syndrome 10 2.7 Treatment and Management Pattern: 11 2.8 company Pipeline Report Guidance 12 3 Sjögren’s Syndrome Therapeutics - Market Characterization 13 3.1 Overview 13 3.2 Sjögren’s Syndrome Therapeutics Market Size (2006-2011) - Global 13 3.3 Sjögren’s Syndrome Therapeutics Market Forecast (2011-2019) - Global 14 3.4 Sjögren’s Syndrome Therapeutics Market Size (2006-2011) - The US 15 3.5 Sjögren’s Syndrome Therapeutics Market Forecast (2011-2019) - The US 16 3.6 Sjögren’s Syndrome Therapeutics Market Size (2006-2011) - France 17 3.7 Sjögren’s Syndrome Therapeutics Market Forecast (2011-2019) - France 18 3.8 Sjögren’s Syndrome Therapeutics Market Size (2006-2011) - Germany 19 3.9 Sjögren’s Syndrome Therapeutics Market Forecast (2011-2019) - Germany 20 3.10 Sjögren’s Syndrome Therapeutics Market Size (2006-2011) - Italy 21 3.11 Sjögren’s Syndrome Therapeutics Market Forecast (2011-2019) - Italy 22 3.12 Sjögren’s Syndrome Therapeutics Market Size (2006-2011) - Spain 23 3.13 Sjögren’s Syndrome Therapeutics Market Forecast (2011-2019) - Spain 24 3.14 Sjögren’s Syndrome Therapeutics Market Size (2006-2011) - The UK 25 3.15 Sjögren’s Syndrome Therapeutics Market Forecast (2011-2019) - The UK 26 3.16 Sjögren’s Syndrome Therapeutics Market Size (2006-2011) - Japan 27 3.17 Sjögren’s Syndrome Therapeutics Market Forecast (2011-2019) - Japan 28 3.18 Drivers and Barriers for the Sjögren’s Syndrome Therapeutics Market 29 3.18.1 Drivers for the Sjögren’s Syndrome Therapeutics Market 29 3.18.2 Barriers for the Sjögren’s Syndrome Therapeutics Market 29 3.19 Key Events Impacting the Future Market 30 3.20 Opportunity and Unmet Need 30 3.21 Key Takeaway 31 4 Sjögren’s Syndrome Therapeutics - Competitive Assessment 32 4.1 Overview 32 4.2 Strategic Competitor Assessment 32 4.3 Product Portfolio for Major Marketed Products in the Sjögren’s Syndrome Therapeutics Market 33 4.3.1 Stimulants 33 4.3.2 Disease Modifying Drugs (DMARDS) 35 4.3.3 Corticosteroids 35 4.3.4 Off- Label and Over the Counter Drugs 35 4.4 Key Takeaway 35 5 Sjögren’s Syndrome Therapeutics - Pipeline Assessment 36 5.1 Overview 36 5.2 Strategic Pipeline Assessment 36 5.3 Sjögren’s Syndrome Pipeline - Pipeline by Phases of Development 36 5.3.1 Sjögren’s Syndrome Therapeutics - Phase III Pipeline 36 5.3.2 Sjögren’s Syndrome Therapeutics - Phase II Pipeline 37 5.3.3 Sjögren’s Syndrome Therapeutics - Phase I Pipeline 37 5.4 Sjögren’s Syndrome Pipeline by Mechanism of Action 38 5.5 Sjögren’s Syndrome Technology Trends Analytical Framework 39 5.6 Sjögren’s Syndrome Therapeutics - Promising Drugs under Clinical Development 41 5.7 Molecule Profile for Promising Drugs under Clinical Development 41 5.7.1 P-552-02 41 5.8 Key Takeaway 42 6 Sjögren’s Syndrome Therapeutics - Clinical Trials Mapping 43 6.1 Clinical Trials by Country (US, EU5 and Japan) 43 6.2 Clinical Trials by Phase 44 6.3 Clinical Trials by Trial Status 45 6.4 Overall Sponsors 46 6.5 Prominent Sponsors 47 6.6 Top Companies Participating in Sjögren’s Syndrome Therapeutics Clinical Trials 48 7 Sjögren’s Syndrome Therapeutics - Strategic Assessment 49 7.1 Future Market Competition Scenario 49 8 Sjögren’s Syndrome Therapeutics - Future Players 50

8.1 Introduction 50 8.2 Parion Sciences 50 8.3 Kainos Medicine, Inc. 51 9 Sjögren’s Syndrome Therapeutics - Licensing and Partnership Deals 52 10 Sjögren’s Syndrome Therapeutics - Appendix 53 10.1 Definitions 53 10.2 Abbreviations 53 10.3 Methodology 54 10.3.1 Coverage 54 10.3.2 Secondary Research 55 10.3.3 Forecasting 55 10.3.4 Primary Research 58 10.3.5 Expert Panel Validation 58 10.4 Contact Us 58 10.5 Disclaimer 58 10.6 Bibliography 59 1.1 List of Tables Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table Table 48 Table Table Table Table 1: American-European Revised Consensus Criteria for Sjögren’s Syndrome 10 2: Sjögren’s Syndrome Therapeutics Market, Global, Revenue ($m), 2006 - 2011 13 3: Sjögren’s Syndrome Therapeutics Market, Global, Forecast ($m), 2011 - 2019 14 4: Sjögren’s Syndrome Therapeutics Market, The US, Revenue ($m), 2006-2011 15 5: Sjögren’s Syndrome Therapeutics Market, The US, Forecast ($m), 2011-2019 16 6: Sjögren’s Syndrome Therapeutics Market, France, Revenue ($m), 2006-2011 17 7: Sjögren’s Syndrome Therapeutics Market, France, Forecast ($m), 2011-2019 18 8: Sjögren’s Syndrome Therapeutics Market, Germany, Revenue ($m), 2006-2011 19 9: Sjögren’s Syndrome Therapeutics Market, Germany, Forecast ($m), 2011-2019 20 10: Sjögren’s Syndrome Therapeutics Market, Italy, Revenue ($m), 2006-2011 21 11: Sjögren’s Syndrome Therapeutics Market, Italy, Forecast ($m), 2011-2019 22 12: Sjögren’s Syndrome Therapeutics Market, Spain, Revenue ($m), 2006-2011 23 13: Sjögren’s Syndrome Therapeutics Market, Spain, Forecasts ($m), 2011-2019 24 14: Sjögren’s Syndrome Therapeutics Market, The UK, Revenue ($m), 2006-2011 25 15: Sjögren’s Syndrome Therapeutics Market, the UK, Forecasts ($m), 2011-2019 26 16: Sjögren’s Syndrome Therapeutics Market, Japan, Revenue ($m), 2006-2011 27 17: Sjögren’s Syndrome Therapeutics Market, Japan, Forecasts ($m), 2011-2019 28 18: Salagen Clinical Study Details 33 19: Evoxac Clinical Study Details 34 20: Sjögren’s Syndrome Therapeutics - Phase III Pipeline, 2011 36 21: Sjögren’s Syndrome Therapeutics - Phase II Pipeline, 2011 37 22: Sjögren’s Syndrome Therapeutics - Phase I Pipeline, 2011 37 23: Sjögren’s Syndrome Therapeutics - Promising Drugs Under Clinical Development, 2011 41 24: Sjögren’s Syndrome Therapeutics - Clinical Trials by Country, 2011 43 25: Sjögren’s Syndrome Therapeutics - Clinical Trials by Phase, 2011 44 26: Sjögren’s Syndrome Therapeutics - Clinical Trials by Status, 2011 45 27: Sjögren’s Syndrome Therapeutics - Overall Sponsors, 2011 46 28: Sjögren’s Syndrome Therapeutics - Prominent Sponsors, 2011 47 29: Sjögren’s Syndrome Therapeutics - Top Companies Participating in Therapeutics Clinical Trials, 2011 30: 31: 32: 33: Parion Sciences - Sjögren’s Syndrome Therapeutics Pipeline, November 2011 50 Parion Sciences - Sjögren’s Syndrome Therapeutics Pipeline, November 2011 50 Kainos Medicine, Inc. - Sjögren’s Syndrome Therapeutics Pipeline, November 2011 51 Kainos Medicine, Inc.- Sjögren’s Syndrome Therapeutics Pipeline, November 2011 51

1.2 List of Figures Figure Figure Figure Figure Figure Figure Figure 1: 2: 3: 4: 5: 6: 7: Secretory Function in Unaffected People 9 Algorithm for the Treatment and Management of Sjögren’s Syndrome 11 Sjögren’s Syndrome Therapeutics Market, Global, Revenue ($m), 2006 - 2011 13 Sjögren’s Syndrome Therapeutics Market, Global, Forecast ($m), 2011 - 2019 14 Sjögren’s Syndrome Therapeutics Market, The US, Revenue ($m), 2006-2011 15 Sjögren’s Syndrome Therapeutics Market, The US, Forecast ($m), 2011-2019 16 Sjögren’s Syndrome Therapeutics Market, France, Revenue ($m), 2006-2011 17

Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure 48 Figure Figure

8: Sjögren’s Syndrome Therapeutics Market, France, Forecast ($m), 2011-2019 18 9: Sjögren’s Syndrome Therapeutics Market, Germany , Revenue ($m), 2006-2011 19 10: Sjögren’s Syndrome Therapeutics Market, Germany, Forecast ($m), 2011-2019 20 11: Sjögren’s Syndrome Therapeutics Market, Italy, Revenue ($m), 2006-2011 21 12: Sjögren’s Syndrome Therapeutics Market, Italy, Forecast ($m), 2011-2019 22 13: Sjögren’s Syndrome Therapeutics Market, Spain, Revenue ($m), 2006-2011 23 14: Sjögren’s Syndrome Therapeutics Market, Spain, Forecast ($m), 2011-2019 24 15: Sjögren’s Syndrome Therapeutics Market, The UK, Revenue ($m), 2006-2011 25 16: Sjögren’s Syndrome Therapeutics Market, The UK, Forecast ($m), 2011-2019 26 17: Sjögren’s Syndrome Therapeutics Market, Japan, Revenue ($m), 2006-2011 27 18: Sjögren’s Syndrome Therapeutics Market, Japan, Forecast ($m), 2011-2019 28 19: Sjögren’s Syndrome Therapeutics, Key Events Impacting Future Market, 2011 30 20: Opportunity and Unmet Need in the Sjögren’s Syndrome Therapeutics Market, 2011 31 21: Strategic Competitor Assessment of the Major Marketed Products for Sjögren’s Syndrome, 2011 32 22: Sjögren’s Syndrome Therapeutics Pipeline by Phase of Development, 2011 36 23: Sjögren’s Syndrome - Clinical Pipeline by Mechanism Of Action, 2011 38 24: Technology Trends Analytical Framework, 2011 39 25: Technology Trends Analytical Framework - Description, 2011 40 26:Clinical Trial Details for P-552-02 41 27: Sjögren’s Syndrome Therapeutics - Clinical Trials by Country, 2011 43 28: Sjögren’s Syndrome Therapeutics - Clinical Trials by Phase, 2011 44 29: Sjögren’s Syndrome Therapeutics - Clinical Trials by Status, 2011 45 30: Sjögren’s Syndrome Therapeutics - Overall Sponsors, 2011 46 31: Sjögren’s Syndrome Therapeutics - Prominent Sponsors, 2011 47 32: Sjögren’s Syndrome Therapeutics - Top Companies Participating in Therapeutics Clinical Trials, 2011 33: Sjögren’s Syndrome Therapeutics, Strategic Assessment, 2011 49 34: company Market Forecasting Model 57

Companies Mentioned Parion Sciences Kainos Medicine, Inc

For more information, please visit: http://www.aarkstore.com/reports/Sj%C3%B6gren%E2%80%99s-Syndrome-TherapeuticsPipeline-Assessment-and-Market-Forecasts-to-2019-192594.html Or email us at contact@aarkstore.com or call +918149852585
More Reports Solar Module Recycling - A Necessary Step to Maximize Environmental Benefits of Solar PV Industry Geothermal Power - Global Market Size, Technology Analysis, Regulations and Key Country Analysis to 2020 Advanced Clean Energy Storage Devices - Global Market Size, Market Analysis by Major Storage Device, and Competitive Landscape to 2020 Thin-Film PV - Global Market Size, Price Analysis, Regulations and Competitive Landscape to 2020 Wind Operations & Maintenance (O&M) Market - Global Market Size, Share by Component, Competitive Landscape and Key Country Analysis to 2020 Compact Fluorescent Lamp (CFL) Market - Global Market Size, Price Analysis, Regulations and Key Countries Analysis to 2020 Biofuels (Biodiesel and Bioethanol) Market - Global Production, Regulations, Export-Import Analysis and Key Country Analysis to 2020 Wind Repowering - Capacity, Generation and Cost-Benefit Analysis to 2020 Oil and Gas Capital Expenditure Outlook, 2012 Offshore Oil and Gas Developments in Asia-Pacific - Burgeoning Energy Demand Drives Exploration and Production Activities Strategic Pipelines Set to Change Geopolitical and Demand Supply Paradigm in the Global Oil and Gas Industry Coal Seam Gas (CSG/CBM) in Asia, 2011 - Market Analysis, Investment Scenario, Competitive Landscape and Production Forecasts to 2015

Refining Industry in Asia-Pacific - Market Analysis, Competitive Landscape and Capacity Forecasts to 2016 Floating Production Storage and Offloading (FPSO) Industry - Global Market Analysis, Competitive Landscape and Planned Projects to 2015 Bakken Shale, 2011 - Oil Shale Market Analysis and Forecasts to 2020 Fayetteville Shale in the US, 2011 - Gas Shale Market Analysis and Forecasts to 2020 Niobrara Shale in the US, 2012 - Oil Shale Market Analysis and Forecasts to 2020 Utica Shale, 2012 - Oil and Gas Market Analysis and Forecasts to 2020 Haynesville Shale in the US, 2012 - Gas Shale Market Analysis and Forecasts to 2020 Montney Shale in Canada, 2012 - Gas Shale Market Analysis and Forecasts to 2020 Nuclear Condensate and Feed Water Pumps - Global Market Size, Pricing, Regional Analysis and Competitive Landscape to 2020 Nuclear Moisture Separator Reheaters Market - Global Market Size, Pricing Analysis, Regional Analysis and Competitive Landscape to 2020 Plant Life Extension (PLEX) and Plant Life Management (PLIM) for Nuclear Reactors - Global Landscape Analysis to 2020 Phase Shifting Transformers for Power Transmission - Global Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 High-Voltage Direct Current (HVDC) Converter Stations - Global Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 Steam Turbines in Asia-Pacific - Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 Shunt Reactor for Power Transmission - Global Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 Power Boilers in Asia Pacific - Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 Gas Turbines in BRIC (Brazil, Russia, India and China) - Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 Heat Recovery Steam Generator (HRSG) Market in Asia-Pacific Region - Market Size, Pricing Analysis, Equipment Market Share and Competitive Landscape Analysis to 2020 High Voltage Direct Current (HVDC) Cables - Global Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 Gas Turbines for Thermal Power - Global Market Size, Average Pricing, Equipment Market Share and Competitive Landscape Analysis to 2020 Wireless Communication Modules for Smart Meters - Market Analysis and Forecasts to 2020 Smart Grid Vendor Landscape Analysis - Strategic Activity Analysis and Outlook to 2015 In-Home Displays for Energy Management - Market Analysis and Forecasts to 2020 Smart Grid Market and Technology Outlook - Industry Trends and Competitive Analysis Smart Grid Landscape in Europe - Market Size, Key Issues, Regulations, Investment Analysis and Outlook to 2020 Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020 Parkinson's Disease Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020 Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020 Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020 Graft Versus Host Disease (GVHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Eczema Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Overactive Bladder (OAB) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Gaucher’s Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Atherosclerosis or Coronary Artery Disease (CAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Venous Thromboembolism (VTE) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Gallbladder Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Myasthenia Gravis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Peptic Ulcer Therapeutics- Pipeline Assessment and Market Forecasts to 2018 Ankylosing Spondylitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Vitiligo Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Rhabdomyosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Laryngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Infantile Spasms Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Unstable Angina Therapeutics - Pipeline Assessment and Market Forecast to 2018 Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Interstitial Cystitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Osteopenia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Athlete’s Foot Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Lyme Disease - Pipeline Assessment and Market Forecasts to 2018 Melanoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Sjögren’s Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Sarcoidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Polycystic Kidney Disease (PKD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Liposarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Nasopharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Graves’ Disease Therapeutics - Pipeline Assessment and Market Forecast to 2019 Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Pompe Disease (GAA Deficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 HIV-Associated Diarrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Aplastic Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Chronic Urticaria or Hives Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Hepatic Encephalopathy - Pipeline Assessment and Market Forecasts to 2019 Hunter Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Syphilis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Narcolepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Myelofibrosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Pulmonary Embolism (PE) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Diabetic Gastroparesis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Hereditary Angioedema Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Anal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Bile Duct Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Polycythemia Vera Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Respiratory Syncytial Virus (RSV) Prophylactic - Pipeline Assessment and Market Forecasts to 2019 Cushing’s Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Social Anxiety Disorders (SAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Vaginitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Clostridium difficile Infection (CDI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Amyloidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Aspergillosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Psychotic Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Gonorrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Childhood Epilepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Anti-Obesity Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Urinary Tract Infections (UTI) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019 Multiple Sclerosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Leiomyosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Waldenström’s Macroglobulinemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Panic Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Postmenopausal Vaginal Atrophy Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Tourette Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Full-Field Digital Mammography Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Refractive Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Intraocular Lens (IOL) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Cataract Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Vision Care Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Blood Glucose Monitoring Devices (Meters, Test Strips, Lancets) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Multiparameter Patient Monitoring - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Picture Archiving and Communication Systems (PACS) - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 Central Venous Catheters - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Hearing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Electrosurgical Devices Market - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018 Infusion Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Compression Therapy - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018 Wound Closure Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018 Non-Invasive Blood Pressure Monitors Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Patient Monitoring Accessories (Patient Monitoring Leads and Electrodes, Non-Invasive Blood Pressure Cuffs and Patient Monitoring Temperature Probes) Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Histology And Cytology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Haematology in BRICS Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Respiratory Measurement Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Immuno Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Compression Therapy Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Traditional Wound Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Wound Closure Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Pressure Relief Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Advanced Wound Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Ostomy Drainage Bags Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Negative Pressure Wound Therapy (NPWT) Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Flexible Endoscopes Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Rigid Endoscopes Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Capsule Endoscope Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Clinical Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Aarkstore Enterprise Tel : +912227453309 Mobile No:+08149852585 Email : contact@aarkstore.com Website : http://www.aarkstore.com Blog: http://www.emarketreports.com Follow us on twitter: http://twitter.com/aarkstoredotcom http://in.linkedin.com/in/aarkstore http://www.facebook.com/aarkstoreenterprise http://www.aarkstore.com/feeds/globaldata.xml

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->